SI1761257T1 - Uporaba acetil-L-karnitina za pripravo zdravila za zdravljenje nevropatske bolečine pri diabetičnih bolnikih - Google Patents

Uporaba acetil-L-karnitina za pripravo zdravila za zdravljenje nevropatske bolečine pri diabetičnih bolnikih

Info

Publication number
SI1761257T1
SI1761257T1 SI200531946T SI200531946T SI1761257T1 SI 1761257 T1 SI1761257 T1 SI 1761257T1 SI 200531946 T SI200531946 T SI 200531946T SI 200531946 T SI200531946 T SI 200531946T SI 1761257 T1 SI1761257 T1 SI 1761257T1
Authority
SI
Slovenia
Prior art keywords
carnitine
acetyl
medicine
preparation
treatment
Prior art date
Application number
SI200531946T
Other languages
English (en)
Slovenian (sl)
Inventor
Menotti Calvani
Antonino Amato
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of SI1761257T1 publication Critical patent/SI1761257T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
SI200531946T 2004-07-01 2005-04-05 Uporaba acetil-L-karnitina za pripravo zdravila za zdravljenje nevropatske bolečine pri diabetičnih bolnikih SI1761257T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000327A ITRM20040327A1 (it) 2004-07-01 2004-07-01 Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
EP05730316.6A EP1761257B1 (en) 2004-07-01 2005-04-05 Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients
PCT/EP2005/003557 WO2006002698A1 (en) 2004-07-01 2005-04-05 Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients

Publications (1)

Publication Number Publication Date
SI1761257T1 true SI1761257T1 (sl) 2015-04-30

Family

ID=34965656

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200531946T SI1761257T1 (sl) 2004-07-01 2005-04-05 Uporaba acetil-L-karnitina za pripravo zdravila za zdravljenje nevropatske bolečine pri diabetičnih bolnikih

Country Status (14)

Country Link
US (2) US20060004095A1 (enExample)
EP (1) EP1761257B1 (enExample)
JP (1) JP5519907B2 (enExample)
KR (1) KR101176347B1 (enExample)
CA (1) CA2570268C (enExample)
CY (1) CY1116171T1 (enExample)
DK (1) DK1761257T3 (enExample)
ES (1) ES2532497T3 (enExample)
IT (1) ITRM20040327A1 (enExample)
MX (1) MXPA06014907A (enExample)
PL (1) PL1761257T3 (enExample)
PT (1) PT1761257E (enExample)
SI (1) SI1761257T1 (enExample)
WO (1) WO2006002698A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230002B1 (en) * 2000-12-15 2015-04-28 Sigma Tau Ind Farmaceuti Use of l-carnitine for preparation of compositions for stabilizing the proteins
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1133010B (it) * 1980-05-15 1986-07-09 Sigma Tau Ind Farmaceuti Metodo terapuetico per il trattamento del diabete mellito a insorgenza giovanile e composizione farmaceutica per tale metodo
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
IT1224842B (it) * 1988-12-27 1990-10-24 Sigma Tau Ind Farmaceuti Uso di derivati della l-carnitina nel trattamento terapeutico delle alterazioni degenerative del sistema nervoso
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
US5827886A (en) * 1997-05-07 1998-10-27 Thione International, Inc. Composition for relief of arthritis-induced symptoms
IT1294227B1 (it) * 1997-08-01 1999-03-24 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1306178B1 (it) * 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
ITRM20010294A1 (it) * 2001-05-29 2002-11-29 Sigma Tau Ind Farmaceuti Uso della acetil l-carnetina in associazione con la biotina per il trattamento di pazienti affetti da diabete mellito di tipo ii insulino re

Also Published As

Publication number Publication date
CA2570268C (en) 2013-10-15
JP5519907B2 (ja) 2014-06-11
ITRM20040327A1 (it) 2004-10-01
EP1761257A1 (en) 2007-03-14
ES2532497T3 (es) 2015-03-27
DK1761257T3 (en) 2015-03-23
PT1761257E (pt) 2015-04-14
KR20070042963A (ko) 2007-04-24
MXPA06014907A (es) 2007-03-21
CA2570268A1 (en) 2006-01-12
CY1116171T1 (el) 2017-02-08
WO2006002698A1 (en) 2006-01-12
JP2008505134A (ja) 2008-02-21
EP1761257B1 (en) 2014-12-31
US20060004095A1 (en) 2006-01-05
KR101176347B1 (ko) 2012-08-24
PL1761257T3 (pl) 2015-06-30
US20070213408A1 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
AP2644A (en) Traditional chinese medicine preparation for cardiocerebral blood vessel diseases and its preparing method
ZA200805716B (en) Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
PL2134259T3 (pl) Urządzenie do nakłuwania skóry pacjenta
GB2439393B (en) Cannabinoids for use in the treatment of neuropathic pain
IL242537A (en) (s) –n– (3– chloro – 4 – cyanophenyl) –3– (4 – cyanophenoxy) –2 – hydroxy – 2 – methylpropanamide for the preparation of cancer and other disease treatment
IL186662A (en) Use of bis (thiohydrazide amide) to prepare a drug for the treatment of human cancer
IL187220A (en) Use of sodium arsenite sodium in the preparation of a drug for the treatment of metastatic tumor diseases
PL2104452T3 (pl) Urządzenie do nakłuwania skóry pacjenta
GB0516601D0 (en) Further medical use of a botanical drug or dietary supplement
ZA200710800B (en) Melthod and apparatus for the non-invasive sensing of glucose in a human subject
EP2063902A4 (en) THERAPEUTIC CELL MEDICAMENT WITH STEM CELLS OF SKIN
IL205290A (en) A variant of human neurorthin protein, or its active biological part, containing medicinal preparations, and its use in the preparation of therapeutic drugs
ZA201003291B (en) Device for delivering a plurality of medical treatment liquids to a human or animal patient
AP2008004379A0 (en) Use of agomelatine in obtaining medicaments intended for the treatment of sleep disorder in the depressed patient
PL1761257T3 (pl) Zastosowanie acetylo-L-karnityny podczas przygotowania leku do leczenia bólu neuropatycznego u pacjentów cukrzycowych
GB2435425B (en) Medical wound healing treatment
GB0603630D0 (en) Medical wound healing treatment
PT2160213E (pt) Conjunto para tratamento extracorporal de um fluido biológico de um paciente, e unidade dotada do referido conjunto
PL1904044T3 (pl) Zastosowanie kombinacji obejmującej L- karnitynę lub alkanoilo-L-karnitynę, rozpuszczalny w tłuszczach benzochinon oraz wielonienasycony kwas tłuszczowy omega-3 do wytwarzania suplementu diety lub leku do leczenia chorób rogówki
HUP0402381A3 (en) Monohydroxycarbamazepine for use in the preparation of a medicament for the treatment of affective and attention disorder and neuropathic pain
IL218069A (en) Oligoscride compounds, drug, pharmaceutical, and compound for its use in therapy
EP1774975A4 (en) USE OF A HUMAN LYSOZYM PREPARATION FOR THE TREATMENT OF ACNE
GB0524514D0 (en) Medical wound healing treatment
EP1945171A4 (en) MANUFACTURE OF A MEDICAL DEVICE AND USE IN ALTERNATIVE MEDICINE FOR REHABILITATION TREATMENT OF CHRONIC DISEASES
IL200192A (en) Use of l-cannitin and / or alkonial l-carnitine, or their common pharmaceutical salt, in combination with statin, for the preparation of a drug for the treatment of type 2 diabetes